GOVX : Summary for GEOVAX LABS INC COM STK USD0.01 - Yahoo Finance

U.S. Markets close in 2 hrs 59 mins

GeoVax Labs, Inc. (GOVX)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.060.00 (0.00%)
At close: 3:56PM EST
People also watch
SNGXHDVYADLSAEMDILNS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.06
Open0.07
Bid0.00 x
Ask0.00 x
Day's Range0.06 - 0.07
52 Week Range0.05 - 0.11
Volume271,904
Avg. Volume211,040
Market Cap3.23M
Beta-0.67
PE Ratio (TTM)-0.79
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research6 days ago

    GOVX: Multiple Progress Made in the Last Two Months

    By Grant Zeng, CFA OTC:GOVX New CSO Appointed On December 14, 2016, GeoVax (OTC:GOVX) announced that the company has promoted Farshad Guirakhoo , PhD, to the role of Chief Scientific Officer (CSO), effective ...

  • Marketwired18 days ago

    GeoVax Media and Presentation Update

    GeoVax Labs, Inc. , a biotechnology company developing human vaccines using its novel platform technology, today noted that its Chief Scientific Officer, Farshad Guirakhoo, PhD, has been featured in the ...

  • Marketwired28 days ago

    GeoVax Announces Initiation of HIV Human Clinical Trial

    GeoVax Labs, Inc. , a biotechnology company developing human vaccines, announced today the initiation of the next human clinical trial of GeoVax's preventive HIV vaccine, GOVX-B11. The Phase 1 trial is ...